AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,726,026 | -19.7% | 479,540 | 0.0% | 0.10% | -9.1% |
Q2 2023 | $4,641,947 | -11.7% | 479,540 | 0.0% | 0.11% | -12.0% |
Q1 2023 | $5,255,758 | +153.7% | 479,540 | 0.0% | 0.12% | +150.0% |
Q4 2022 | $2,071,613 | -74.2% | 479,540 | -55.0% | 0.05% | -75.8% |
Q3 2022 | $8,019,000 | -2.1% | 1,066,408 | +30.8% | 0.21% | -13.0% |
Q2 2022 | $8,192,000 | -14.2% | 815,126 | +5.7% | 0.24% | -0.8% |
Q1 2022 | $9,545,000 | -8.7% | 771,018 | +68.6% | 0.24% | -0.8% |
Q4 2021 | $10,456,000 | -23.0% | 457,173 | -25.5% | 0.24% | -15.1% |
Q3 2021 | $13,572,000 | +33.3% | 613,269 | -22.0% | 0.28% | +41.8% |
Q2 2021 | $10,184,000 | +0.3% | 785,769 | +0.5% | 0.20% | -9.0% |
Q1 2021 | $10,149,000 | -5.1% | 781,569 | +1.0% | 0.22% | -2.6% |
Q4 2020 | $10,700,000 | -6.0% | 773,669 | +0.1% | 0.23% | -21.5% |
Q3 2020 | $11,380,000 | – | 772,569 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |